| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| methyl (4R)-4-[(5R,8R,9S,10S,12S,13R,14S,17R)-12-acetoxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
|
443913-73-3 |
詳細(xì)
|
| (1S)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-Pyrido[2,3-d]pyrimidin-2(1H)-one |
|
775304-57-9 |
詳細(xì)
|
| Serotonin hydrochloride |
|
153-98-0 |
詳細(xì)
|
| PF-06882961 |
|
1088994-22-2 |
詳細(xì)
|
| Ivacaftor |
|
700874-72-2 |
詳細(xì)
|
| Bortezomib |
|
1231930-82-7 |
詳細(xì)
|
| Vortioxetine |
|
1202757-89-8 |
詳細(xì)
|
| Chelest Mg 40 |
|
14402-88-1 |
詳細(xì)
|
| 3-(trifluoromethyl)pyridine |
|
3796-23-4 |
詳細(xì)
|
| 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-2-[(12R)-12-methyl-13-oxa-2,4,10-triazatricyclo[7.4.0.03]trideca-1(9),2,5,7-tetraen-10-yl]-N-[3-nitro-4-(tetrahydropyran-4-ylmethylamino)phenyl]sulfonyl-benzamide |
|
475110-96-4 |
詳細(xì)
|
| Lumateperone |
|
4105-38-8 |
詳細(xì)
|
| DL-Propranolol |
|
525-66-6 |
詳細(xì)
|
| 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methyl-pyridine-2-carboxamide;hydrate;dihydrochloride |
|
2222138-27-2 |
詳細(xì)
|
| Necrostatin 2 racemate |
|
852391-15-2 |
詳細(xì)
|
| 4-methoxy-N-[5-(4-pyridyl)-8-quinolyl]benzenesulfonamide |
|
2126164-27-8 |
詳細(xì)
|
| 2-[(1S,5R)-3-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hexan-6-yl]acetic acid |
|
2102501-84-6 |
詳細(xì)
|
| (7R,14R)-11-Chloro-1-(difluoromethoxy)-6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one |
|
1956435-30-5 |
詳細(xì)
|
| methyl 2-(rel-(1R,5S,6r)-3-(2-((S)-2-methylazetidin-1-yl)-6-(trifluoromethyl)pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-6-yl)acetate |
|
2102501-83-5 |
詳細(xì)
|
| (3R,5R,8R,9R,10S,13S,14S,17E)-17-ethylidene-3,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-ol |
|
1430063-91-4 |
詳細(xì)
|
| LOXO-101 |
|
480449-70-5 |
詳細(xì)
|
| (3S,8S,9S,10R,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
|
357166-30-4 |
詳細(xì)
|
| Exatecan mesylate |
|
827022-32-2 |
詳細(xì)
|
| 9-bromo-2-iodo-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine |
|
1282516-69-1 |
詳細(xì)
|
| NSC 60534 |
|
183319-69-9 |
詳細(xì)
|
| Deferasirox |
|
1369490-06-1 |
詳細(xì)
|
| 1-(4-bromo-2-fluorophenyl)ethan-1-one |
|
625446-22-2 |
詳細(xì)
|
| NSC 33942 |
|
317318-70-0 |
詳細(xì)
|
| Elagolix sodium salt |
|
844499-71-4 |
詳細(xì)
|
| GSK-356278 |
|
936727-05-8 |
詳細(xì)
|
| cis-2-fluorocyclopropane-1-carboxylic acid |
|
105919-34-4 |
詳細(xì)
|
| 1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol;hydrochloride |
|
1260141-27-2 |
詳細(xì)
|
| N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide |
|
928672-86-0 |
詳細(xì)
|
| NSC 23349 |
|
6974-32-9 |
詳細(xì)
|
| (3S,4R)-4-[[5-chloro-4-[7-fluoro-2-(1-hydroxy-1-methyl-ethyl)-3-isopropyl-benzimidazol-5-yl]pyrimidin-2-yl]amino]tetrahydropyran-3-ol |
|
875320-31-3 |
詳細(xì)
|
| (1H-pyrazol-4-yl)boronic acid |
|
763120-58-7 |
詳細(xì)
|
| Palbociclib |
|
242478-38-2 |
詳細(xì)
|
| Suzetrigine |
|
2649467-58-1 |
詳細(xì)
|
| Cholesteryl 6-aminohexylcarbamate hydrochloride |
|
1226805-77-1 |
詳細(xì)
|
| 5-thiazolecarboxamide, 2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-n-(2-hydroxy-6-methylphenyl)- |
|
1159977-25-9 |
詳細(xì)
|
| Riociguat |
|
709031-78-7 |
詳細(xì)
|
| AQW-051 |
|
52806-53-8 |
詳細(xì)
|
| 1-(4-chlorophenyl)-7-oxo-6-[4-(2-oxo-1-piperidyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide |
|
53251-94-8 |
詳細(xì)
|
| 6-chloropyrimidin-4-amine |
|
5305-59-9 |
詳細(xì)
|
| 4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide |
|
52-49-3 |
詳細(xì)
|
| (αR)-α-[[(5S)-5-[3-Chloro-2-methyl-4-[2-(4-methyl-1-piperazinyl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy]-2-[[2-(2-methoxyphenyl)-4-pyrimidinyl]methoxy]benzenepropanoic acid |
|
1799631-75-6 |
詳細(xì)
|
| an-2728 |
|
627052-25-9 |
詳細(xì)
|
| Moxidectin |
|
113507-06-5 |
詳細(xì)
|
| Saroglitazar magnesium |
|
503612-47-3 |
詳細(xì)
|
| OWL 833 |
|
345627-80-7 |
詳細(xì)
|
| RX 811056 |
|
3663-80-7 |
詳細(xì)
|
| Altiratinib |
|
1206161-97-8 |
詳細(xì)
|
| VX-661 |
|
1044870-39-4 |
詳細(xì)
|
| Ponatinib hydrochloride |
|
1114544-31-8 |
詳細(xì)
|
| Ponesimod |
|
1160221-25-9 |
詳細(xì)
|
| LOXO-101 |
|
1223403-58-4 |
詳細(xì)
|
| 4-[2-[2-(azetidin-3-yl)pyrazol-3-yl]-4-(trifluoromethyl)phenoxy]-5-chloro-2-fluoro-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide |
|
1193314-24-7 |
詳細(xì)
|
| PF-04447943 |
|
91374-20-8 |
詳細(xì)
|
| 2-amino-2-(hydroxymethyl)propane-1,3-diol 2-[[4-[6-[(4-cyano-2-fluoro-phenyl)methoxy]-2-pyridyl]-1-piperidyl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid |
|
2230198-03-3 |
詳細(xì)
|
| 1-allyl-3,5-bis(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione |
|
850649-62-6 |
詳細(xì)
|
| Duloxetine hydrochloride |
|
404-86-4 |
詳細(xì)
|
| Lenvatinib |
|
211914-51-1 |
詳細(xì)
|
| Encenicline hydrochloride |
|
550999-74-1 |
詳細(xì)
|
| Venetoclax |
|
1257044-40-8 |
詳細(xì)
|
| 2-methyl-1-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propan-2-ol |
|
1082503-77-2 |
詳細(xì)
|
| NSC 168386 |
|
1259305-29-7 |
詳細(xì)
|
| 6-[(1-acetylpiperidin-4-yl)amino]-N-[(2R)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide |
|
1377049-84-7 |
詳細(xì)
|
| Saroglitazar magnesium |
|
1639792-20-3 |
詳細(xì)
|
| benzyl N-{1-[3,5-bis(trifluoromethyl)phenyl]-1-oxopropan-2-yl}carbamate |
|
1973485-18-5 |
詳細(xì)
|
| Cabotegravir |
|
157212-55-0 |
詳細(xì)
|
| Tofacitinib |
|
131-48-6 |
詳細(xì)
|
| KDS-0071 |
|
191217-81-9 |
詳細(xì)
|
| tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate |
|
668270-12-0 |
詳細(xì)
|
| Gleevac |
|
220127-57-1 |
詳細(xì)
|
| BGB-3111 |
|
1268524-70-4 |
詳細(xì)
|
| Venetoclax |
|
960203-27-4 |
詳細(xì)
|
| Trametinib |
|
1037792-44-1 |
詳細(xì)
|
| Chlorochin |
|
54-05-7 |
詳細(xì)
|
| Apabetalone |
|
1952316-43-6 |
詳細(xì)
|
| Palbociclib hydrochloride |
|
1691249-44-1 |
詳細(xì)
|
| BK-40143 |
|
2426584-49-6 |
詳細(xì)
|
| Virgaureagenin B |
|
161735-79-1 |
詳細(xì)
|
| N-[(3R)-3-(2-chloro-5-fluoro-phenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-isoindolin-4-yl]-3-fluoro-5-(trifluoromethyl)benzamide |
|
136434-34-9 |
詳細(xì)
|
| ABBV-744 |
|
148849-67-6 |
詳細(xì)
|
| Ruxolitinib phosphate salt |
|
1092939-17-7 |
詳細(xì)
|
| Levomilnacipran hydrochloride |
|
175131-60-9 |
詳細(xì)
|
| Chelest Mg 40 |
|
1229194-11-9 |
詳細(xì)
|
| (7R)-2-(4-phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4H,5H,6H,7H-pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
1032900-25-6 |
詳細(xì)
|
| N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonyl-anilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide |
|
370879-49-5 |
詳細(xì)
|
| NSC 9269 |
|
2393-23-9 |
詳細(xì)
|
| tert-butyl N-(4-bromopyridin-2-yl)carbamate |
|
207799-10-8 |
詳細(xì)
|
| DuP 532 |
|
124750-95-4 |
詳細(xì)
|
| N-[(5-thioxo-6H-pyrazolo[1,5-c]quinazolin-2-yl)methyl]-2-(trifluoromethoxy)benzamide |
|
3004683-22-8 |
詳細(xì)
|
| Ipragliflozin |
|
475207-59-1 |
詳細(xì)
|
| lusutrombopag |
|
1035270-39-3 |
詳細(xì)
|
| 2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide |
|
1389264-17-8 |
詳細(xì)
|
| Empagliflozin |
|
832720-36-2 |
詳細(xì)
|
| AZD-4547 |
|
1345847-93-9 |
詳細(xì)
|
| Nintedanib |
|
171599-83-0 |
詳細(xì)
|
| PF 06700841-15 |
|
2140301-96-6 |
詳細(xì)
|
| 4-bromo-1H-pyrazol-5-amine |
|
16461-94-2 |
詳細(xì)
|